Positron emission tomography in cancer of the head and neck

British Journal of Oral and Maxillofacial Surgery

Volumn 43, Issue 1, 2005, Pages 1-6

  Hain, Sharon F ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

FDG; Head and neck cancer; PET; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEAD AND NECK CANCER; HUMAN; IMAGE QUALITY; LYMPH NODE METASTASIS; MEDICAL ASSESSMENT; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUANTITATIVE ANALYSIS; SALIVARY GLAND CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR LOCALIZATION;

EID: 11844296661     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2004.09.006     Document Type: Review

References (44)

1. M.P. Stokkel F.W. ten Brock P.P. van Rijk The role of FDG PET in the clinical management of head and neck cancer Oral Oncol. 34 1998 466-471
2. W.F. McGuirt K.M. Greven J.W. Keyes et al. Positron emission tomography in the evaluation of laryngeal carcinoma Ann Otol Rhinol Laryngol 104 1995 274-278
3. S. Manolidis P.J. Donald P. Volk et al. The use of positron emission tomography scanning in occult and recurrent head and neck cancer Acta Otolaryngol Suppl 534 1998 1-11
4. E. Di-Martino B. Nowak H.A. Hassan et al. Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings Arch Otolarnygol Head Neck Surg 126 2000 1457-1461
5. H. Minn M. lapela P.J. Klemi et al. Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer J Nucl Med 38 1997 1907-1911
6. W. Halfpenny S.F. Hain L. Biassoni et al. FDG-PET. A possible prognostic factor in head and neck cancer Br J Cancer 86 2002 512-516
7. S. Ali R. Tiwari G. Snow False positive and false negative neck nodes Head Neck 8 1985 78-82
8. E. Bocca C. Calearo I. de Vincentis et al. Occult metastases in cancer of the larynx and their relationship to the clinical and histological aspects of the primary tumor: A 4-year multicentric research Laryngoscope 94 1984 1086-1090
9. M. Freidman V.K. Shelton M. Mafee et al. Metastatic neck disease. Evaluation by computed tomography Arch otolaryngol 110 1984 443-447
10. J.W. Braams J. Pruim N.J. Freiling et al. Detection of lymph node metastates of squamous cell cancer of the head and neck with FDG-PET and MRI J Nucl Med 36 1995 211-216
11. M. Benchaou W. Lehmann D.O. Slosman et al. The role of FDG-PET in the pre-operative assessment of N staging in head and neck cancer Acta Otolaryngol 116 1996 332-335
12. T. Stuckensen A.F. Kovacs S. Adams et al. Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI J Craniomaxillofac Surg 28 2000 319-324
13. C. Laubenbacher D. Saumweber C. Wwagner-Mmanslau et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous cell carcinomas J Nucl Med 36 1995 1747-1757
14. W.F. McGuirt D.W. Williams J.W. Keyes et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography Laryngoscope 105 1995 373-375
15. E. Kresnik P. Mikosch H.J. Gallowitsch et al. Evaluation of head and neck cancer with 18F-FDG-PET: A comparison with conventional methods Eur J Nucl Med 28 2001 816-821
16. M. Van den Brekel J. Castelijns H. Stel et al. Cervical lymph nodes metastases: Assessment of radiologic criteria Radiology 180 1981 457-461
17. S.J. Stoeckli H. Steinert M. Pfaltz S. Schmid Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma Head Neck 24 2002 345-349
18. N.C. Hyde E. Prvulovich L. Newman W.A. Waddington D. Visirkis P. Ell A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: The role of sentinel node biopsy and positron emission tomography Oral Oncol 39 2003 350-360
19. C.S. Hollenbeak V.J. Lowe B.C. Stack Jr. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck Cancer 92 2001 2341-2348
20. D.L. Schwartz J. Rajendran B. Yueh et al. Staging of head and neck squamous cell cancer with extdended field FDG-PET Arch Otolaryngol Head Neck Surg 129 2003 1173-1178
21. G.W. Gores D.T. Schmid K.W. Gratz et al. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity Oral Oncol 39 2003 547-551
22. M.K. Wax L.L. Myers E.C. Gabalski et al. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer Arch Otolaryngol Head Neck Surg 128 2002 703-707
23. S. Partridge A. Timothy M.J. O'Doherty S.F. Hain S. Rankin G. Mikhaeel 2-Fluorine-18-fluoro-2-deoxy- d glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: Influence on patient management in a single institution Ann Oncol 11 2000 1273-1279
24. C.A.B. Saunders J. Dussek M.J. O'Doherty M.N. Maisey An evaluation of 18F-FDG whole body PET imaging in the staging of lung cancer Ann Thoracic Surg 67 1999 790-797
25. 18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional modalities J Oral Maxillofac Surg 61 2003 1022-1029
26. J.W. Keyes N.E. Watson D.W. Williams et al. FDG-PET in head and neck cancer Am J Roentgenol 169 1997 1663-1669
27. Y. Anzai W.R. Caroll D.J. Quint et al. Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F18]fluoro- d -glucose PET and MR imaging diagnoses Radiology 200 1996 135-141
28. M. Lonneux G. Lawson C. Ide et al. Positron emission tomography with fluorodeoxyglucose for suspected head and neck cancer recurrence in the symptomatic patient Laryngoscope 111 2000 1493-1497
29. K.M. Greven D.W. Williams J.W. Keyes et al. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 3 1997 353-357
30. M. Lapela A. Eigtve S. Jyrkkio et al. Experience in qualitative and quantative FDGPET in follow-up of patients with suspected recurrence from head and neck cancer Eur J Cancer 36 2000 858-867
31. V.J. Lowe J.H. Boyd F.R. Dunphy et al. Surveillance for recurrent head and neck cancer using positron emission tomography J Clin Oncol 18 2000 651-658
32. R.J. Wong D.T. Lin H. Schoder et al. Diagnostic and prognostic value of [(18)F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma J Clin Oncol 20 2002 4199-4208
33. 18 F]-2-fluorodeoxyglucose-positron emission tomography: Implications for prognosis and patient management Cancer 98 2003 2257-2265
34. E. Brun E. Kjellen J. Tennvall et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 2002 127-135
35. V.J. Lowe Fr. Dunphy M. Varvares et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18] fluorodeoxyglucose positron emission tomography Head Neck 19 1997 666-674
36. M. Jungehulsing K. Scheidhauer M. Damm et al. 2[F]-fluoro-2-deoxy- d -glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation Otolaryngol Head Neck Surg 123 2000 294-301
37. A.C. Kole O.E. Nieweg J. Pruim et al. Detection of unknown occult primary tumors using positron emission tomography Cancer 82 1998 160-166
38. O.S. Aasar N.J. Fischbein G.R. Caputo et al. Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors Radiology 210 1999 177-181
39. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT) Eur J Cancer 35 1999 1076-1082
40. J.W. Keyes B.A. Harkness K.M. Greven et al. Salivary gland tumours: pretherapy evaluation with PET Radiology 192 1994 99-102
41. E. Goshen O. Cohen G. Rotenberg et al. The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma Nucl Med Commun 24 2003 959-961
42. W.J. Koh J.S. Rasey M.L. Evans et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole Int J Radiat Oncol Biol Phys 22 1992 199-212
43. J.R. De Boer J. Pruim F. Burlage et al. Therapy evaluation of laryngeal carcinomas by tyrosine-PET Head Neck 25 2003 634-644
44. E. Chesnay E. Babin J.M. Constans Early response to chemotherapy in hypopharyngeal cancer: Assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome J Nucl Med 44 2003 526-532